Contents Volume 16 · Issue 3 · 2022. Pages 307-506 14 articles
Analysis of interactions of immune checkpoint inhibitors with antibiotics in cancer therapy
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 307-321 doi:10.1007/s11684-022-0927-0
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 322-338 doi:10.1007/s11684-021-0901-2
Fine-tuning cell organelle dynamics during mitosis by small GTPases
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 339-357 doi:10.1007/s11684-022-0926-1
Microorganism-derived biological macromolecules for tissue engineering
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 358-377 doi:10.1007/s11684-021-0903-0
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 378-388 doi:10.1007/s11684-021-0840-y
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 389-402 doi:10.1007/s11684-021-0856-3
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 403-415 doi:10.1007/s11684-021-0858-1
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 416-428 doi:10.1007/s11684-021-0838-5
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 429-441 doi:10.1007/s11684-021-0842-9
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 442-458 doi:10.1007/s11684-021-0877-y
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 459-466 doi:10.1007/s11684-021-0841-x
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 467-482 doi:10.1007/s11684-021-0869-y
Characterization of chromatin accessibility in psoriasis
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 483-495 doi:10.1007/s11684-021-0872-3
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 496-506 doi:10.1007/s11684-021-0828-7